Patent ID: 9018375
Filing Date: 2015-04-28
Classification: A61K,A61P,C07D,Y02A

Abstract:
1. A method for the treatment of chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), acute myeloid leukemia (AML), multiple myeloma (MM), or small lymphocytic lymphoma (SLL), comprising the step of administering to a subject in need thereof an effective amount of compound of the formula or a tautomer thereof, N-oxide thereof, pharmaceutically acceptable ester thereof, prodrug thereof, or pharmaceutically acceptable salt thereof, wherein each occurrence of R is independently selected from hydrogen, halogen, —OR R Cy Cy L each occurrence of R n is an integer from 1 to 4; and q is 0, 1 or 2.